FDMT
Price
$4.57
Change
-$0.04 (-0.87%)
Updated
Jul 25 closing price
Capitalization
211.7M
12 days until earnings call
IMNM
Price
$10.87
Change
-$0.37 (-3.29%)
Updated
Jul 25 closing price
Capitalization
945.82M
18 days until earnings call
Interact to see
Advertisement

FDMT vs IMNM

Header iconFDMT vs IMNM Comparison
Open Charts FDMT vs IMNMBanner chart's image
4D Molecular Therapeutics
Price$4.57
Change-$0.04 (-0.87%)
Volume$231.32K
Capitalization211.7M
Immunome
Price$10.87
Change-$0.37 (-3.29%)
Volume$572.15K
Capitalization945.82M
FDMT vs IMNM Comparison Chart in %
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. IMNM commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and IMNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (FDMT: $4.57 vs. IMNM: $10.87)
Brand notoriety: FDMT and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 58% vs. IMNM: 57%
Market capitalization -- FDMT: $211.7M vs. IMNM: $945.82M
FDMT [@Biotechnology] is valued at $211.7M. IMNM’s [@Biotechnology] market capitalization is $945.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • FDMT’s TA Score: 4 bullish, 3 bearish.
  • IMNM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both FDMT and IMNM are a good buy in the short-term.

Price Growth

FDMT (@Biotechnology) experienced а +8.29% price change this week, while IMNM (@Biotechnology) price change was +2.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

FDMT is expected to report earnings on Nov 05, 2025.

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($946M) has a higher market cap than FDMT($212M). IMNM YTD gains are higher at: 2.354 vs. FDMT (-17.953). IMNM has higher annual earnings (EBITDA): -175.18M vs. FDMT (-196.46M). FDMT (321M) and IMNM (317M) have equal amount of cash in the bank . IMNM has less debt than FDMT: IMNM (4.77M) vs FDMT (23.9M). IMNM has higher revenues than FDMT: IMNM (10.9M) vs FDMT (23K).
FDMTIMNMFDMT / IMNM
Capitalization212M946M22%
EBITDA-196.46M-175.18M112%
Gain YTD-17.9532.354-763%
P/E RatioN/AN/A-
Revenue23K10.9M0%
Total Cash321M317M101%
Total Debt23.9M4.77M501%
TECHNICAL ANALYSIS
Technical Analysis
FDMTIMNM
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRERX52.690.26
+0.50%
MFS Core Equity R2
SVXLX67.22N/A
N/A
Smead International Value Inv
GRMAX29.60N/A
N/A
Nationwide S&P 500 Index A
RYMRX22.20N/A
N/A
Guggenheim Multi-Hedge Strategies C
TVLIX12.43N/A
N/A
Touchstone Value Institutional

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-0.87%
IDYA - FDMT
47%
Loosely correlated
-1.33%
RGNX - FDMT
46%
Loosely correlated
-1.86%
BEAM - FDMT
45%
Loosely correlated
+3.68%
MNMD - FDMT
43%
Loosely correlated
+0.41%
IMNM - FDMT
42%
Loosely correlated
-3.29%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-3.29%
IDYA - IMNM
60%
Loosely correlated
-1.33%
RXRX - IMNM
55%
Loosely correlated
+3.67%
BEAM - IMNM
54%
Loosely correlated
+3.68%
SYRE - IMNM
53%
Loosely correlated
+1.08%
DNTH - IMNM
53%
Loosely correlated
-1.33%
More